Literature DB >> 17413183

Novel insights in dopamine receptor physiology.

Rosario Pivonello, Diego Ferone, Gaetano Lombardi, Annamaria Colao, Steven W J Lamberts, Leo J Hofland.   

Abstract

The dopaminergic system has a pivotal role in the central nervous system but also plays important roles in the periphery, mainly in the endocrine system. Dopamine exerts its functions via five different receptors, named D(1)-D(5), belonging to the category of G protein coupled membrane receptors. Dopamine receptors are heterogeneously expressed in different cells, tissues and organs, where they stimulate or inhibit different functions, including neurotransmission and hormone synthesis and secretion. In particular, the dopamineric system has a pivotal role in the physiological regulation of the hypothalamus-pituitary-adrenal axis. Recent data have demonstrated the expression and function of dopamine receptors not only in endocrine organs but also in endocrine tumors, mainly those belonging to the hypothalamus-pituitary-adrenal axis, and also in the so-called 'neuroendocrine' tumors. These data confirm the important role of the dopaminergic system in this endocrine axis, as well as in the neuroendocrine system. This review summarizes the main structural and functional characteristics of dopamine receptors, emphasizing the most recent novelties, and focused on the physiological and pathological regulation of the hypothalamus-pituitary-adrenal axis by the dopaminergic system. In addition, the recent findings on the relationship between dopamine receptors and neuroendocrine tumors are summarized.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413183     DOI: 10.1530/eje.1.02353

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  40 in total

1.  PharmGKB summary: dopamine receptor D2.

Authors:  Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-06       Impact factor: 2.089

Review 2.  Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials.

Authors:  Rosario Pivonello; Rosario Ferrigno; Maria Cristina De Martino; Chiara Simeoli; Nicola Di Paola; Claudia Pivonello; Livia Barba; Mariarosaria Negri; Cristina De Angelis; Annamaria Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-08       Impact factor: 5.555

Review 3.  Molecular basis of pharmacological therapy in Cushing's disease.

Authors:  Diego Ferone; Claudia Pivonello; Giovanni Vitale; Maria Chiara Zatelli; Annamaria Colao; Rosario Pivonello
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

Review 4.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

5.  Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland.

Authors:  Rosario Pivonello; Marlijn Waaijers; Johan M Kros; Claudia Pivonello; Cristina de Angelis; Alessia Cozzolino; Annamaria Colao; Steven W J Lamberts; Leo J Hofland
Journal:  Endocrine       Date:  2016-10-13       Impact factor: 3.633

6.  Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells.

Authors:  Jiao-Jiao Xu; Si-Yuan Wang; Ye Chen; Guang-Ping Chen; Zai-Quan Li; Xue-Yan Shao; Liang Li; Wei Lu; Tian-Yan Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

7.  Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers.

Authors:  Christopher H So; Vaneeta Verma; Mohammad Alijaniaram; Regina Cheng; Asim J Rashid; Brian F O'Dowd; Susan R George
Journal:  Mol Pharmacol       Date:  2009-01-26       Impact factor: 4.436

8.  Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly.

Authors:  Leonardo Vieira Neto; Evelyn de O Machado; Raul M Luque; Giselle F Taboada; Jorge B Marcondes; Leila M C Chimelli; Leonardo Pereira Quintella; Paulo Niemeyer; Denise P de Carvalho; Rhonda D Kineman; Mônica R Gadelha
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

9.  Dopamine D1 and D2 dopamine receptors regulate immobilization stress-induced activation of the hypothalamus-pituitary-adrenal axis.

Authors:  Xavier Belda; Antonio Armario
Journal:  Psychopharmacology (Berl)       Date:  2009-07-21       Impact factor: 4.530

10.  Source of dopamine in gastric juice and luminal dopamine-induced duodenal bicarbonate secretion via apical dopamine D2 receptors.

Authors:  Xiao-Yan Feng; Jing-Ting Yan; Guang-Wen Li; Jing-Hua Liu; Rui-Fang Fan; Shi-Chao Li; Li-Fei Zheng; Yue Zhang; Jin-Xia Zhu
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.